Frontiers in Reproductive Health: How might we motivate uptake of the Dual Prevention Pill?
Findings from human-centered design research with potential end users, male partners and healthcare providers
AVAC’s Wawira Nyagah and Kate Segal co-authored a comprehensive manuscript on a demand generation approach for the DPP (Dual Prevention Pill) including findings from research with potential users, male partners, and healthcare providers.
Read the abstract below and the full published research article here.
Multipurpose prevention technologies (MPTs) combining contraception with HIV prevention offer a promising solution to uptake and adherence challenges faced with oral pre-exposure prophylaxis (PrEP). The Dual Prevention Pill (DPP), which combines oral PrEP with an oral contraceptive pill (OCP), could address unmet need for family planning (FP) and HIV prevention. This study aimed to identify barriers and motivators for DPP uptake to inform the development of a DPP demand generation strategy and broader introduction efforts for MPTs.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!